Look for bargains in European stockmarkets
With the continent looking towards a robust recovery and markets at much lower valuations than the US, there are plenty of bargains to be found in European stocks.
The euro area is “nearing escape velocity”, says Christopher Graham of Standard Chartered. Economies have been gradually easing restrictions. France and Austria reopened restaurants last week, while Portugal and Italy are welcoming tourists from certain countries. The continent should enjoy a “robust recovery” now.
European vaccination rates picked up rapidly in April, says Ian Shepherdson of Pantheon Macroeconomics. More than half of the population should have had at least one jab by the end of June, only a month behind the US. Data from Israel suggests that “cases plummet… when vaccination rates exceed about 50%”.
Analysts turn positive
Germany’s Dax hit a new all-time high this week. Wall Street analysts are growing positive, says Sam Meredith for CNBC. Morgan Stanley thinks “Europe is well-placed to outperform all major regions this year for the first time in more than two decades”. With inflation anxiety affecting US markets, more US money managers are looking to the old continent.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The MSCI EMU index has outperformed the MSCI USA index since “vaccine Monday” on 9 November 2020 (the date when news of the Pfizer jab broke), says Franziska Palmas of Capital Economics. While Europe’s recovery will be weaker than America’s, its shares should keep outperforming.
US earnings forecasts are already very bullish, so a lot of good news is already priced in. In Europe a slower reopening has made analysts much more conservative, leaving room for positive surprises.
European markets are also far cheaper than their US counterparts. As of the start of this quarter the US market was trading on a cyclically adjusted price/earnings (Cape) ratio of 36.1. By contrast, Germany was on 19.9, France on 22.6 and Spain on just 14.7, according to Mebane Faber of Cambria Investment Management. That discount partly reflects compositional differences. The US has more fast-growing tech firms, while Europe has more value shares, such as banks and industrial firms.
Yet composition doesn’t explain the whole story. As Simon Edelsten notes in the Financial Times, even firms operating in similar industries are cheaper in Europe. Shares in German sportswear giant Adidas trade for “35 times this year’s earnings, but Nike in the US is on an eye-watering 42 times earnings”. The same is true of banks.
But “before dashing across the Channel like an excited shopper hunting for duty-free Gitanes and Château Plonque”, remember that cheap shares are sometimes cheap for a reason. Europe’s very best businesses – those that operate in sectors such as luxury goods and green energy – are rarely the cheapest. “Don’t be afraid to compromise on price in favour of prospects.”
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Four AI ETFs to buy
Is now a good time to buy AI ETFs? We examine four AI ETFs that investors might want to add to their portfolio
By Dan McEvoy Published
-
Chase boosts easy-access interest rate - savers could earn 4.75%
Chase is offering a boosted interest rate which is fixed for six months, on top of the standard variable rate
By Jessica Sheldon Published
-
Is there value in European equities?
European equities are in the bargain basement owing to a stagnant economy – but tread carefully
By Rupert Hargreaves Published
-
India's stock market drops - why it's thrown investors into frenzy
Nifty 50, India's stock market index, has dropped 8% from a September record amid concerns of an economic slowdown and foreign investors pulling out
By Alex Rankine Published
-
Warren Buffet invests in Domino’s – should you buy?
What makes Domino's a compelling investment for Warren Buffet's Berkshire Hathaway, and should you buy the UK-listed takeaway pizza chain?
By Dr Matthew Partridge Published
-
4Imprint makes a strong impression – should you buy?
4Imprint, a specialist in marketing promotional products, is the leader in a fragmented field
By Dr Mike Tubbs Published
-
Invest in Glencore: a cheap play on global growth
Glencore looks historically cheap, yet the group’s prospects remain encouraging
By Rupert Hargreaves Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Key takeaways from the MoneyWeek Summit 2024: Investing in a dangerous world
If you couldn’t get a ticket to MoneyWeek’s summit, here’s an overview of what you missed
By MoneyWeek Published
-
DCC: a top-notch company going cheap
DCC has a stellar long-term record and promising prospects. It has been unfairly marked down
By Jamie Ward Published